Invited by the Hong Kong Intellectual Property Department (IPD), our President, Dr. Jacqueline Lui, gave a talk for the IP Manager Training Program on Management and Exploitation of Patents.
我們過去活動
Recommended Insights
Twice the Trouble: Unraveling a Single Case of Dual Patent and Trademark Infringement
2024年1月9日Can a rights holder sue the same infringer separately based on one single infringing act that infringes both trademark and patent rights? An interesting case this year from China’s Supreme People’s Court that addresses this specific issue ((2023)最高法知民终235号). Beijing Run De Hong Tu Technology Development Co., Ltd. (“Run De Hong Tu”) sued an individual named […]
閱讀更多 >
CHINA: How Prohibiting "Illegal" Inventions Runs into Food Safety Law
2021年10月22日Chinese Patent Law has an interesting provision that specifically prohibits patent protection on “illegal” or “immoral” inventions. What does this mean, exactly? According to Article 5.1 of the Chinese Patent Law, “no patent shall be granted for an invention that contravenes any law or social moral or that is detrimental to public interests.” On its […]
閱讀更多 >
Beijing IP Court Reverses CNIPA Decision and Upholds Ozempic® semaglutide patent in China as VALID based on Novo Nordisk’s Post Filing Data
2024年6月27日Recently, all eyes have been on China as the fundamental patent covering semaglutide, the active ingredient in Ozempic® and Wegovy®, will expire on March 20, 2026. It goes without saying that generics are ramping up bigtime in China (and also around the world), preparing to manufacture and sell this blockbuster drug to one of the […]
閱讀更多 >
China’s Newest Examination Guidelines: Novelty and Inventive Step for Compounds (Part II)
2021年4月29日This is Part II of a three-part series summarizing the Examination Guidelines that were released by the CNIPA on January 15, 2021, one year to the date of Phase 1 of the US and China Economic and Trade Agreement. That agreement included specific provisions where China "shall permit pharmaceutical patent applicants to rely on supplemental […]
閱讀更多 >